WTSIi139-A
HPSI1113i-oaaz_2
iPSC line
At European Collection of Authenticated Cell Cultures (ECACC)
A CLIP contains information about a cell line including any
specific third party obligations relating to, for example,
licensing obligations or the donor consent which affect the
use of the cell line.
A batch specific Certificate of Analysis will be available to
download once you receive your EBiSC iPSC line.
General#
Cell Line |
|
| hPSCreg Name | WTSIi139-A |
| Alternative name(s) |
HPSI1113i-oaaz_2
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
WTSIi139-B (HPSI1113i-oaaz_3) |
Provider |
|
| Depositor | Wellcome Sanger Institute (WTSI) |
| Distributors |
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)
|
| Derivation country | United Kingdom |
External Databases |
|
| hPSCreg | WTSIi139-A |
| BioSamples | SAMEA2459970 |
| HipSci | HPSI1113i-oaaz_2 |
| Cellosaurus | CVCL_AH97 |
| ECACC | 77650187, 66540248 |
| CLO | CLO_0101148 |
| Wikidata | Q54891648 |
General Information |
|
| Publications | View all related publications on hPSCreg (1) |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information#
General Donor Information |
|
| Sex | male |
| Age of donor (at collection) | 70-74 |
| Ethnicity | White - White British |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Donor Relations |
|
| Other cell lines of this donor |
|
External Databases (Donor) |
|
| BioSamples | SAMEA2399135 |
| HipSci | HPSI-oaaz |
hIPSC Derivation#
General |
|
| Source cell type |
fibroblastA connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.
|
| Source cell origin |
zone of skinAny portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
|
| Age of donor (at collection) | 70-74 |
| Collected in | 2014 |
| Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Genes | |
| Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
| Selection criteria for clones | Morphology |
| Derived under xeno-free conditions |
No |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions#
The following are the depositor culture conditions, they do not refer to any specific batch.
| Surface coating | Vitronectin |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| CO2 Concentration | 5 % |
| Medium |
TeSR™ E8™
|
Characterisation#
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
| POU5F1 (OCT-4) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| NANOG |
Yes |
|
| Pluripotency Score | Novelty Score | Link to microarray data |
| 46.691 | 1.339 | http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4057/ |
Report
HPSI-oaaz.pluritest.pluripotency_score.20161010.png
pluripotency image
HPSI-oaaz.pluritest.novelty_score.20161010.png
novelty image
Genotyping#
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
| Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ266775
cnv
http://www.hipsci.org/lines/#/lines/HPSI1113i-oaaz_2 Number of regions different from primary tissue: 2; Length of differences from primary tissue: 5 |
| WGS-derived disease associations |
Charcot-Marie-Tooth disease (FIG4)
Cohen syndrome (VPS13B)
collagen 6-related myopathy (COL6A2)
complex neurodevelopmental disorder (SETBP1)
demyelinating hereditary motor and sensory neuropathy (MTMR2)
Kleefstra syndrome (EHMT1)
mitochondrial disease (NDUFS6)
monogenic diabetes (ABCC8, PAX4)
mucopolysaccharidosis type 4A (GALNS)
nephronophthisis 4 (NPHP4)
nonsyndromic genetic hearing loss (MYO7A)
PHARC syndrome (ABHD12)
primary ciliary dyskinesia 5 (HYDIN)
primary ciliary dyskinesia 7 (DNAH11)
renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (ATP6V1B1)
Rothmund-Thomson syndrome (RECQL4)
Schinzel-Giedion syndrome (SETBP1)
Smith-Magenis syndrome (RAI1)
syndromic intellectual disability (KMT2C)
Usher syndrome type 1 (MYO7A)
|
| Other WGS-derived genes | AGL, ALDH3A2, ATXN3, AURKC, BMP4, CARD8, CASP12, CASP8, CATSPER2, CHST15, CLDN16, COLQ, CYP21A2, D2HGDH, DEFB126, DNAH9, DSC3, ERCC6L2, FCGR2A, FUT2, GALNT3, GLYCTK, GPR161, H6PD, HLA-DRB5, HSD17B13, IRF5, ITGB2, KCNJ16, LAMA5, MAPT, MROH8, MTTP, NDUFB9, NFU1, NOTCH2, OR52B4, P2RX5, PDE4DIP, PIGN, POLDIP2, POLR3B, PRKRA, RAD52, RNASEH2B, RXFP2, SCAPER, SH3BP2, SIGLEC12, SLC37A4, SPATA7, SRA1, TBP, TDG, TGIF1, TMEM107, TMEM216, TNRC18, TREH, TRPM1, TUBB8, VDR, VRK1, WDR37, ZAN, ZNF124 |